Conversely, previous studies suggested a protective role for the CaSR in intestinal inflammation, which highlights the CaSR as a promising target for inflammatory bowel disease (IBD) treatment [17,18,19]. The gene discussed is CASR; the disease is inflammatory bowel disease.